The Truth About Peptides, IV Therapy & Biohacking (What Doctors Aren’t Saying). In this episode of The Paths We Take, we sit down with Amy Thomas, founder of Hydralyfe Australia, to explore the rapidly growing world of biohacking, peptides, IV therapy, and longevity medicine.We dive into the shift happening in Australia as more people move toward preventative, data-driven, and personalised healthcare and away from a purely symptom-based model of traditional medicine.Amy shares her personal journey into the space, what led her to build Hydralyfe, and how experiences with ADHD, burnout, and conventional healthcare shaped her perspective on health optimisation and integrated care.We break down:What peptides and IV therapy actually are (beyond the social media hype)Why biohacking is becoming more mainstream in AustraliaThe differences between conventional medicine and longevity-focused health careThe importance of blood testing, data, and personalised treatmentThe risks, regulations, and misconceptions around emerging therapiesHow men and women are approaching preventative health differentlyWhy the future of healthcare is likely a blend of traditional + functional medicineThis episode is not medical advice but a deep, honest conversation about where health, science, and personal responsibility are heading.Whether you’re curious, sceptical, or already exploring biohacking, this conversation gives a grounded look into one of the fastest-evolving spaces in health and wellness.

find Hydralyfe on instagram https://www.instagram.com/hydralyfe_australia